Table 5. Prevalence and distribution of ESBL-producing E. coli isolates from beef and sheep meat.
|
Anti-biotic |
Type |
Sylhet (n1=29, n2=14) |
Moulvibazar (n1=20, n2=11) |
Sunamgonj (n1=19, n2=10) |
Habigonj (n1=22, n2=11) |
Total (N1=90, N2=46) |
P valuea |
|
Cefo |
Beef |
12(41.37%) |
15 (75%) |
17 (89.47%) |
16 (72.72%) |
60 (66.66%) |
0.003# |
|
Sheep |
4 (28.57%) |
7 (63.63%) |
9 (90%) |
4 (36.36% |
24 (52.17%) |
0.129## |
|
|
Cefta |
Beef |
29(100%) |
19 (95%) |
19 (100%) |
22 (100%) |
89 (98.89%) |
0.013# |
|
Sheep |
8 (57.14%) |
7 (63.63%) |
9 (90%) |
11 (100%) |
35 (76.09%) |
0.513## |
|
|
Ceftri |
Beef |
12 (41.37%) |
10 (50%) |
12 (63.16% |
14 (63.64%) |
48 (53.33%) |
0.043# |
|
Sheep |
6 (42.85%) |
9 (81.82%) |
4 (40%) |
5 (45.45%) |
24 (52.17%) |
0.918## |
|
|
Az |
Beef |
18 (62.06%) |
14(70%) |
11 (57.89%) |
15 (68.18%) |
58 (64.44%) |
0.016# |
|
Sheep |
9 (64.28%) |
6 (54.55%) |
8 (80%) |
9 (81.82%) |
32 (69.57%) |
0.298## |
|
|
bCefo +Ceftri |
Beef |
7 (24.13%) |
3 (15%) |
5 (26.32%) |
4 (18.18%) |
19 (21.11%) |
0.015# |
|
Sheep |
1 (7.14%) |
1 (9.09%) |
0 |
0 |
2 (4.35%) |
0.435## |
n1=number of E. coli isolates from beef sample,n2=number of E. coli isolates from sheep meat sample. N1= Total number of E. coli isolates from beef sample, N2= Total number of E. coli isolates from sheep meat sample.Cefo = Cefotaxime, Cefta = Ceftazidime, Ceftri = Ceftriaxone, Azo=Aztreonam, Cefo +Ceftri= Cefotaxime +Ceftriaxone.a An unreplicated two-way analysis of variance (ANOVA) was used to calculate the P values. P values less than 0.05 are bolded. # Variance between beef and sheep meat. ## Variance among the four districts under study.b E. coli isolate showing resistance to both Cefotaxime and Ceftriaxone was considered ESBL-producing in accordance with the recommendations by the Centers for Disease Control and Prevention (CDC).